BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1858205)

  • 1. [Vitamin K1 and C metabolism in uremia during hemodialysis].
    Bakaev VV; Khomenko VF
    Urol Nefrol (Mosk); 1991; (1):40-3. PubMed ID: 1858205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vitamin K1 and C excretion by the kidneys in chronic kidney failure].
    Bakaev VV; Khomenko VF; Titiaev II
    Urol Nefrol (Mosk); 1993; (6):42-4. PubMed ID: 8160321
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostacyclin and thromboxane in chronic uremia: effect of hemodialysis.
    Ylikorkala O; Huttunen K; Järvi J; Viinikka L
    Clin Nephrol; 1982 Aug; 18(2):83-7. PubMed ID: 6754193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies of the metabolism of fibrinogen-I 125 in cases of chronic glomerulonephritis and pyelonephritis and in uremic patients treated by periodical hemodialysis].
    Huber W; Previato G; Bertoli M; Cancarini GC; Toigo G; Gasparotto ML; Romagnoli GF
    G Clin Med; 1975; 56(11-12):431-44. PubMed ID: 1233337
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oxalic acid--important uremic toxin].
    Mydlík M; Derzsiová K
    Vnitr Lek; 2010 Jul; 56(7):695-701. PubMed ID: 20842915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc tolerance tests in chronic uremia.
    Antoniou LD; Shalhoub RJ; Elliot S
    Clin Nephrol; 1981 Oct; 16(4):181-7. PubMed ID: 7296977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extracellular and intracellular water-electrolyte changes and acid-base equilibrium changes after extracorporeal hemodialysis in chronic uremic patients].
    Acquarone N; Bertocchi I; De Ferrari G; Gurreri G; Menozzi PG; Tizianello A
    Minerva Nefrol; 1970; 17(6):190-7. PubMed ID: 5516054
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in plasma levels of vitamin C during hemodialysis in patients with chronic uremia].
    Dite P; Krch V; Groh J
    Tunis Med; 1968; 46(4):329-35. PubMed ID: 5713845
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
    Washio K; Inagaki M; Tsuji M; Morio Y; Akiyama S; Gotoh H; Gotoh T; Gotoh Y; Oguchi K
    Nephron Clin Pract; 2008; 109(2):c49-54. PubMed ID: 18544955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in plasma concentrations of hypoxanthine and uric acid before and after hemodialysis.
    Shahbazian H; Zand Moghadam A; Ehsanpour A; Khazaali M
    Iran J Kidney Dis; 2009 Jul; 3(3):151-5. PubMed ID: 19617664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc metabolism in uremia.
    Mahajan SK; Prasad AS; Rabbani P; Briggs WA; McDonald FD
    J Lab Clin Med; 1979 Nov; 94(5):693-8. PubMed ID: 501198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acid-base balance in haemodialyzed patients].
    Hrabcáková P; Mydlík M; Molcányiová A
    Vnitr Lek; 2002 Oct; 48(10):959-61. PubMed ID: 16737145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoperoxidation and hemodialysis.
    Ramos R; Martínez-Castelao A
    Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.
    Böhm V; Tiroke K; Schneider S; Sperschneider H; Stein G; Bitsch R
    Int J Vitam Nutr Res; 1997; 67(4):262-6. PubMed ID: 9285256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.